The fundamental analysis focuses on free cash flow yield as a key metric, identifying stocks growing their balance sheet and provides investor security. The analyst identifies three specific stocks: Salesforce, Applied Materials, and Gilead Sciences, and mentions the price predictions for each one. Salesforce, with ticker CRM, has a 5.06% free cash flow yield, most of its ten billion revenue coming from recurring revenue and has a price forecast of $325.23. Applied Materials, with ticker AMAT, has a 3.07% free cash flow yield and is positioned to benefit from growth in AI and data centers with 1.4 billion in buybacks with a high estimate up to 300 and an average target price for 2025 of $226.09. The third stock, Gilead Sciences, with ticker GILD, and a 6.19% free cash flow, and a forecast average target price of $129.13, and has existing proven drug portfolio used to treat HIV and Hepatitis C. No risk analysis is provided.